Status:
UNKNOWN
Surgical Innovation for Diabetes Treatment 2
Lead Sponsor:
Hospital de Sao Sebastiao
Collaborating Sponsors:
Instituto de Ciências Biomédicas Abel Salazar
The Novo Nordisk Foundation Center for Basic Metabolic Research
Conditions:
Enteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric Procedures
Determine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the Superobese
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to understand the enteroendocrine physiological changes in superobese patients submitted to two different bariatric procedures (biliopancreatic diversion with duodenal switch versus si...
Detailed Description
Abstract Obesity is a chronic disease whose global incidence keeps rising as the twenty first century goes on. Nowadays, the surgical approach constitutes the best treatment option for these patients,...
Eligibility Criteria
Inclusion
- Bariatric surgery candidates
- BMI between 45 and 55 kg/m2
- Aged between 18 and 65 years at surgery
Exclusion
- Previous abdominal surgery
- Diabetic patients (Hb A1c \> 5,7%) prior to the bariatric procedure
- Treatment with antidiabetic drugs, except for purposes other than diabetes treatment, prior to the bariatric procedure
Key Trial Info
Start Date :
August 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04712409
Start Date
August 16 2020
End Date
February 1 2025
Last Update
August 17 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
São Sebastião Hospital
Santa Maria da Feira, Aveiro District, Portugal, 4520-211
2
Hospital de São Sebastião
Santa Maria da Feira, Portugal